CGON (CG Oncology) Long-Term Capital Lease Obligation : $0.07 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is CG Oncology Long-Term Capital Lease Obligation?

CG Oncology's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was $0.07 Mil.

CG Oncology's quarterly Long-Term Capital Lease Obligation declined from Mar. 2024 ($0.18 Mil) to Jun. 2024 ($0.12 Mil) and declined from Jun. 2024 ($0.12 Mil) to Sep. 2024 ($0.07 Mil).

CG Oncology's annual Long-Term Capital Lease Obligation increased from Dec. 2021 ($0.05 Mil) to Dec. 2022 ($0.26 Mil) but then declined from Dec. 2022 ($0.26 Mil) to Dec. 2023 ($0.24 Mil).

CG Oncology Long-Term Capital Lease Obligation Historical Data

The historical data trend for CG Oncology's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CG Oncology Long-Term Capital Lease Obligation Chart

CG Oncology Annual Data

Trend

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

0.05

0.26

0.24

CG Oncology Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial					0.30	0.24	0.18	0.12	0.07

CG Oncology (NAS:CGON) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

CG Oncology Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of CG Oncology's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

CG Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618

Website

https://www.cgoncology.com

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.